Stock Picks. Is the Options Market Predicting a Spike in MEI Pharma (MEIP) Stock? MEI Pharma - MEIP - Stock Price Today - Zacks Its drug candidates include Pracinostat, an oral HDAC inhibitor . MEI Pharma, Inc. (MEIP) Analyst Ratings, Estimates & Forecasts - Yahoo! See MEI Pharma, Inc. (MEIP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. MEI Pharma (NASDAQ:MEIP), Analyst Ratings, Price Targets, Predictions What is MEIP's Earnings Per Share (EPS) forecast for 2022-2024? MEIP - MEI Pharma Inc Stock quote - CNNMoney.com Find real-time MEIP - MEI Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. MEI PHARMA INC Stock Forecast, Predictions & Price Target Mei Pharma Inc (MEIP) Latest News & Price | InvestorPlace A. The average twelve-month price prediction for MEI Pharma is $5.13 with a high price target of $20.00 and a low price target of $1.00. A development stage company, engaged in the clinical development of the anti-cancer drug phenoxodiol. MEI PHARMA INC Stock Forecast, Predictions & Price Target Will MEI Pharma, Inc. (MEIP) Report Negative Q2 Earnings? What You ... Actuals. MEIP Stock Forecast, Price & News (MEI Pharma) - MarketBeat Learn more on MEIP's analyst rating . (Expected Surprise Prediction) looks to find companies that have recently seen . These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. MEI Pharma (MEIP) Stock Price, News & Info | The Motley Fool Today's 52-Week Highs; Today's 52-Week Lows; Volume . This means that if you invested $100 now, your current investment may be worth 0$ on 2023 June 05, Monday. The average price target represents a 787.78% change from the last price of $0.56. MEI Pharma Stock Forecast & Price Targets - TipRanks MEIP : 0.5566 (-6.03%) MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments Business Wire - Mon Feb 7, 7:00AM CST. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. Mei Pharma Inc (MEIP) Latest News & Price | InvestorPlace (NASDAQ: MEIP) MEI PHARMA's current Earnings Per Share (EPS) is -$0.41. In-depth view of key statistics and finances for MEI PHARMA, INC. (MEIP) on MSN Money. As of 2022 June 05, Sunday current price of MEIP stock is 0.527$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. MEI Pharma stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. MEIP - Research and Analysis for MEI PHARMA, INC. - MSN MEI Pharma, Inc. (MEIP) Latest Stock News | Seeking Alpha MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the expansion of its management team with the addition of two . MEI PHARMA, INC. : Revenue and Earnings Analysts Forecasts Revisions ... MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 31.58% and 139.26%, respectively, for the quarter ended December 2021. MEI Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SAN DIEGO & TOKYO, June 04, 2022--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, today announced data from the ongoing Phase 2 TIDAL study evaluating the . Their forecasts range from $1.00 to $20.00. View MEI Pharma, Inc MEIP investment & stock information. Do the numbers hold clues to what lies ahead for the stock? More. MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at ... is Investigating MEI Pharma, Inc. on Behalf of MEI Stockholders and Encourages Investors to Contact the Firm BU 05/17 Why MEI Pharma Is Tanking 15.3% Today | The Motley Fool About the MEI Pharma Inc stock forecast. . MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. Interactive Chart MEIP S&P 500 Index Compare MEIP Stock to Peers News & Analysis: MEI Pharma. Investors in MEI Pharma, Inc. (MEIP Quick Quote MEIP - Free Report) need to pay close attention to the stock based on moves in the options market lately.That is because the Jun 19, 2020 $5.00 Call . MEI Pharma, Inc. (MEIP) Stock Price Today, Quote & News Future price of the stock is predicted at 0$ ( -100% ) after a year according to our prediction system. MEI Pharma, Inc. (MEIP) Stock Price, Quote & News - Stock Analysis MEI Pharma, Inc. (MEIP) Stock Price Today, Quote & News The highest, average, and lowest price target of all analysts. What was the 52-week high for MEI Pharma stock? msn back to msn home money. MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. MEIP - MEI Pharma Inc Stock quote - CNNMoney.com The. Based on 9 Wall Street analysts offering 12 month price targets for MEI Pharma in the last 3 months. On average, they expect MEI Pharma's share price to reach $5.13 in the next year. In depth view into MEI Pharma Issuance of Stock explanation, calculation, historical data and more MEI Pharma, Inc. (MEIP) Analyst Ratings, Estimates & Forecasts - Yahoo! MEIP | MEI Pharma Inc. Stock Overview (U.S.: Nasdaq) | Barron's . The company's shares closed last Thursday at $1.83, close to its 52-week low of $1.68. While ratings are subjective and will change, the latest MEI Pharma ( MEIP) rating was a maintained with a price target of $11.00 to $4.00. Past 12 Months 12 Months Forecast -$1 $3.25 $7.5 $11.75 $16 Aug 2021 Nov MEI Pharma : Announces Pricing of Public Offering of Common Stock ... MEI Pharma's portfolio of drug candidates . MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates. Quarterly Numbers. msn back to msn home money. MEI Pharma (MEIP) Stock Competitors and Alternatives 2022 In-depth view of key statistics and finances for MEI PHARMA, INC. (MEIP) on MSN Money. MEIP | MEI Pharma Inc. Profile | MarketWatch Q3 2021. Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. The current price MEI Pharma ( MEIP) is trading at is . MEIP updated stock price target summary. The average price target is $5.00 with a high forecast of $15.00 and a low forecast of $1.00. Stock Picks. This suggests a possible upside of 710.9% from the stock's current price. MEIP | MEI Pharma Inc. Stock Overview (U.S.: Nasdaq) | Barron's This company is expected to post quarterly loss of $0.19 per share in its upcoming report, which represents a year-over-year change of +13.6%. MEI Pharma's portfolio of drug candidates contains multiple clinical-stage assets, including zandelisib, currently in ongoing clinical trials which may support marketing approvals with the U.S. Food . MEIP Stock | News | MEI PHARMA Stock Price Today | Analyst Opinions ... MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates About MEI Pharma. The low in the last 52 weeks of MEI Pharma stock was 0.41. MEI Pharma (NASDAQ:MEIP), Analyst Ratings, Price Targets, Predictions MEI Pharma Inc. MEI Pharma, Inc. is a pharmaceutical company, which engages in the clinical development of therapies for cancer. Sat, 04 Jun 2022 MEI Pharma (MEIP) Stock Price: Why It Increased . Get the latest MEI Pharma, Inc MEIP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. MEI Pharma (NASDAQ: MEIP) was reported by BTIG on March 25, 2022.The analyst firm set a price target for $4.00 expecting MEIP to rise to within 12 months (a possible . web search. MEI Pharma expands early-stage zandelisib trial in specific blood cancer cohorts SA News Mon, Jan. 04, 2021 1 Comment MEI Pharma EPS misses by $0.06, beats on revenue According to the issued ratings of 7 analysts in the last year, the consensus rating for MEI Pharma stock is Buy based on the current 3 hold ratings and 4 buy ratings for MEIP. MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates. MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, today announced data from the ongoing Phase 2 TIDAL study evaluating the intermittent dosing of zandelisib, an . MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of -46.67% and 340.09%, respectively, for the quarter ended December 2020. MEI Pharma Stock Forecast & Price Targets - TipRanks . Revenues are expected to be $7.62 million, down 16.9%. MEIP Stock Predictions, Articles, and Mei Pharma Inc News From InvestorPlace From the Web 27 Biotechnology Stocks to Sell Now By Portfolio Grader Nov 7, 2016 This week, 27 Biotechnology stocks are . The latest price target for . What is MEIP's Earnings Per Share (EPS) forecast for 2022-2024? MEIP - Mei Pharma Stock Price - Barchart.com A high-level overview of MEI Pharma, Inc. (MEIP) stock. MEI PHARMA ALERT: Bragar Eagel & Squire, P.C. AC Immune's average media sentiment score of 0.84 beat MEI Pharma's score of -0.42 indicating that AC Immune is being referred to more favorably in the media. MEIP | MEI Pharma Inc. Analyst Estimates | MarketWatch According to the current price, MEI Pharma is 132.93% away from the 52-week low. MEIP Stock | News | MEI PHARMA Stock Price Today | Analyst Opinions ... The average MEI PHARMA stock price prediction forecasts a potential upside of 437.57% from the current MEIP share price of $0.53. MEI Pharma Price Target, Predictions & Analyst Ratings The 6 analysts offering price forecasts for MEI Pharma have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 1.00. MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the expansion of its management team with the addition of two . View analysts' price targets for MEI Pharma or view top-rated stocks among Wall Street analysts. MEIP : 0.5566 (-6.03%) MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments Business Wire - Mon Feb 7, 7:00AM CST. Stock Price Prediction: Update at 5:00pm EST: If tomorrow: Open lower Open higher High: 0.56 - 0.57 0.57 - 0.57 Low: . MEI Pharma, Inc. (MEIP) Stock Price, Quote & News - Stock Analysis The average price target represents a 787.78% change from the last price of $0.56. MEIP - Mei Pharma Stock Barchart Opinion - Barchart.com MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at ... MEIP Issuance of Stock | MEI Pharma - GuruFocus.com On average, they expect MEI Pharma's share price to reach $5.13 in the next year. About MEI Pharma. MEI Pharma (MEIP) Stock Price, News & Info | The Motley Fool Get the latest MEI Pharma, Inc MEIP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. See MEI Pharma, Inc. (MEIP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Today's 52-Week Highs; Today's 52-Week Lows; Volume . The average twelve-month price prediction for MEI Pharma is $5.13 with a high price target of $20.00 and a low price target of $1.00. 52-Week Range $0.41 - $3.55 Dividend & Yield N/A (N/A) MEIP Stock Predictions, Articles, and Mei Pharma Inc News From InvestorPlace From the Web 27 Biotechnology Stocks to Sell Now By Portfolio. MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 31.58% and 139.26%, respectively, for the quarter ended December 2021. Complete MEI Pharma Inc. stock information by Barron's. View real-time MEIP stock price and news, along with industry-best analysis. According to the issued ratings of 7 analysts in the last year, the consensus rating for MEI Pharma stock is Buy based on the current 3 hold ratings and 4 buy ratings for MEIP. MEI Pharma - MEIP - Stock Price Today - Zacks The average price target is $5.00 with a high forecast of $15.00 and a low forecast of $1.00. 6 Wall Street analysts have issued 12-month price targets for MEI Pharma's shares. MEIP - MEI Pharma, Inc., Stock Quote, Analysis, Rating and News 2022-06-04 | NDAQ:MEIP | Press Release | MEI Pharma Inc. Their forecasts range from $1.00 to $20.00. . MEI Pharma (MEIP) stock price prediction is 0 USD. The MEI Pharma stock ... After each calculation, the program assigns a buy, sell or hold value for each study . MEI Pharma Price Target, Predictions & Analyst Ratings The Opinions takes up to 5 years' worth of historical data and runs these prices through thirteen different technical indicators. MEIP Issuance of Stock as of today (June 05, 2022) is $52.26 Mil. Real time MEI Pharma (MEIP) stock price quote, stock graph, news & analysis. Alliance Global Partners analyst Matthew Cross maintained a Buy rating on MEI Pharma (MEIP - Research Report) today and set a price target of $9.00. MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at ... What are analysts forecasts for MEI Pharma stock? MEI Pharma (MEIP) stock price prediction is 0 USD. The MEI Pharma stock ... MEIP Stock Forecast, Price & News (MEI Pharma) - MarketBeat Estimates. This suggests a possible upside of 710.9% from the stock's current price. web search. The average MEI PHARMA stock price prediction forecasts a potential upside of 518.56% from the current MEIP share price of $0.46. MarketBeat recorded 5 mentions for MEI Pharma and 4 mentions for AC Immune. On average, Wall Street analysts predict that MEI PHARMA 's share price could reach $2.83 by Mar 25, 2023.